Global Electroceuticals / Bioelectric Medicine Strategic Research Report 2023: Market to Reach $26.5 Billion by 2030 - Disease-specific Electroceuticals to Drive Future Gains [Yahoo! Finan...
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Electroceuticals / Bioelectric Medicine Market to Reach $26.5 Billion by 2030 The global market for Electroceuticals / Bioelectric Medicine estimated at US$16.4 Billion in the year 2022, is projected to reach a revised size of US$26.5 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is projected to record 7% CAGR and reach US$16.7 Billion by the end of the analysis period. Growth in the Cochlear Implants segment is estimated at 5.2% CAGR for the next 8-year period. The report on electroceuticals/bioelectric medicine provides valuable insights into this emerging market, including the global market share of key competitors in 2022. It also discusses the impact of the COVID-19 pandemic on the electroceuticals/bioelectric medicine market. The report introduces the concept of electro
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise [Seeking Alpha]Seeking Alpha
- Abbott Laboratories (NYSE:ABT) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns? [Yahoo! Finance]Yahoo! Finance
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/23/25 - Form 3
- 12/19/25 - Form 3
- 12/12/25 - Form 4
- ABT's page on the SEC website